#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4738036	B	Inhibition of Wistar rat lens ALR2 assessed as reduction in NADPH oxidation using D,L-glyceraldehyde and NADPH as substrate preincubated for 10 mins followed by substrate addition and measured for 4 mins by spectrophotometric analysis	Rattus norvegicus	25		tissue-based format	Scientific Literature
2.	ALA4738037	B	Inhibition of Wistar rat kidney ALR1 assessed as reduction in NADPH oxidation using sodium D-glucuronate and NADPH as substrate preincubated for 10 mins followed by substrate addition and measured for 4 mins by spectrophotometric analysis	Rattus norvegicus	25		tissue-based format	Scientific Literature
3.	ALA4738038	B	Selectivity index, ratio of IC50 for Wistar rat kidney ALR1 to IC50 for Wistar rat lens ALR2	Rattus norvegicus	25		assay format	Scientific Literature
4.	ALA4738039	B	Potency index, ratio of IC50 of epalrestat to IC50 of compound for inhibition of Wistar rat lens ALR2 using D,L-glyceraldehyde and NADPH as substrate preincubated for 10 mins followed by substrate addition and measured for 4 mins by spectrophotometric analysis	Rattus norvegicus	1		tissue-based format	Scientific Literature
5.	ALA4738040	B	Noncompetitive inhibition of Wistar rat lens ALR2 at 0.025 mM using varying level of D,L-glyeraldehyde as substrate in presence of NADPH by double reciprocal plot analysis	Rattus norvegicus	1		tissue-based format	Scientific Literature
6.	ALA4738041	B	Uncompetitive inhibition of Wistar rat lens ALR2 at 2.5 mM using D,L-glyeraldehyde as substrate in presence of varying levels of NADPH by double reciprocal plot analysis	Rattus norvegicus	1		tissue-based format	Scientific Literature
7.	ALA4738042	F	Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM after 30 mins by spectrophotometric analysis		5		assay format	Scientific Literature
8.	ALA4738043	F	Antioxidant activity in rat brain assessed as inhibition of lipid peroxidation at 50 to 100 uM by TBARS assay	Rattus norvegicus	1		tissue-based format	Scientific Literature
9.	ALA4738044	F	Inhibition of polyol pathway in STZ-induced Kunming mouse model of diabetes assessed as decrease in sorbitol level in kidney cortex at 80 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose by fluorospectrophotometric analysis	Mus musculus	3		organism-based format	Scientific Literature
10.	ALA4738045	F	Inhibition of polyol pathway in STZ-induced Kunming mouse model of diabetes assessed as decrease in sorbitol level in kidney cortex at 160 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose by fluorospectrophotometric analysis	Mus musculus	1		organism-based format	Scientific Literature
11.	ALA4738046	F	Inhibition of polyol pathway in STZ-induced Kunming mouse model of diabetes assessed as decrease in sorbitol level in kidney cortex at 80 mg/kg, po administered QD via gavage for 4 weeks and measured at 6 hrs post-final drug dose by fluorospectrophotometric analysis	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA4738047	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as reduction in liver MDA level at 80 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose relative to STZ-treated group	Mus musculus	3		organism-based format	Scientific Literature
13.	ALA4738048	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as reduction in liver MDA level at 160 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose relative to STZ-treated group	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA4738049	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as reduction in liver MDA level at 80 mg/kg, po administered QD via gavage for 4 weeks and measured at 6 hrs post-final drug dose relative to STZ-treated group	Mus musculus	1		organism-based format	Scientific Literature
15.	ALA4738050	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as reduction in liver MDA level at 80 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose relative to normal group	Mus musculus	1		organism-based format	Scientific Literature
16.	ALA4738051	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as rise in liver MDA level at 160 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose relative to normal group	Mus musculus	1		organism-based format	Scientific Literature
17.	ALA4738052	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as rise in liver MDA level at 80 mg/kg, po administered QD via gavage for 4 weeks and measured at 6 hrs post-final drug dose relative to normal group	Mus musculus	1		organism-based format	Scientific Literature
18.	ALA4738053	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as increase in SOD level in kidney at 80 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose	Mus musculus	1		organism-based format	Scientific Literature
19.	ALA4738054	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as increase in SOD level in kidney at 160 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose	Mus musculus	1		organism-based format	Scientific Literature
20.	ALA4738055	F	Antioxidant activity in STZ-induced diabetic Kunming mouse assessed as increase in GSH level in kidney at 80 mg/kg, po administered daily via gavage for 8 weeks and measured at 6 hrs post-final drug dose by microplate reader analysis	Mus musculus	1		organism-based format	Scientific Literature